Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial by Solaymani-Dodaran, Masoud, Kalantari, Saeed, Banihashemi, Seyed Reza, Es-haghi, Ali, Nofeli, Mojtaba, Mohazzab, Arash, Mokhberalsafa, Ladan, Sadeghi, Fariba, Mokaram, Ali Rezae, Moradi, Monireh Haji, Razaz, Seyad Hossein, Taghdiri, Maryam, Lotfi, Mohsen, Setarehdan, Seyed Amin, Masoumi, Safdar, Ansarifar, Akram, Ebrahimi, Saeedeh, Esmailzadehha, Neda, Boluki, Zahra, Khoramdad, Malihe, Molaipour, Leila, Rabiei, Mohamad Hassan, Amiri, Fahimeh Bagheri, Filsoof, Sara, Bani-vaheb, Behrooz, Derakhshani, Maryam Raghami, Bayazidi, Sheno, Golmoradizadeh, Rezvan, Shahsavan, Masoumeh, Safari, Shiva, Ghahremanzadeh, Neda, Mohseni, Vahideh, Erfanpoor, Saeed, Fallah Mehrabadi, Mohammad Hossein

Get full text